Correction to: Leukemia https://doi.org/10.1038/s41375-023-01923-y, published online 08 May 2023
Following publication of this article, the authors noted an inadvertent error in the assembly of Fig. 4. Specifically, the image in the left panel of Fig. 4E was duplicated in the upper right panel of Fig. 4G. Below is the corrected Fig. 4G.
Additionally, the authors wish to amend a sentence in the Materials and Methods section, under the subsection “RNAFluorescence In Situ Hybridization, Immunohistochemistry, and Immunofluorescence.” Specifically, the first sentence of the second paragraph is revised to: “Immunohistochemistry (IHC) and immunofluorescence were performed as described in the previous study [14].” This change is crucial to clarify that the reference to Reference 14 pertains to the established experimental methods of IHC and immunofluorescence, without implying the authors direct involvement in the cited work’s development of these methods.
The original article has been corrected.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Liu, S., Zhou, J., Ye, X. et al. Correction: A novel lncRNA SNHG29 regulates EP300- related histone acetylation modification and inhibits FLT3-ITD AML development. Leukemia 38, 2069 (2024). https://doi.org/10.1038/s41375-024-02356-x
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41375-024-02356-x